These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26876902)

  • 1. Neuronal replacement: Concepts, achievements, and call for caution.
    Götz M; Bocchi R
    Curr Opin Neurobiol; 2021 Aug; 69():185-192. PubMed ID: 33984604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. iPSCs: A Minireview from Bench to Bed, including Organoids and the CRISPR System.
    Orqueda AJ; Giménez CA; Pereyra-Bonnet F
    Stem Cells Int; 2016; 2016():5934782. PubMed ID: 26880972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome mutational burden analysis of three pluripotency induction methods.
    Bhutani K; Nazor KL; Williams R; Tran H; Dai H; Džakula Ž; Cho EH; Pang AWC; Rao M; Cao H; Schork NJ; Loring JF
    Nat Commun; 2016 Feb; 7():10536. PubMed ID: 26892726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decade of transcription factor-mediated reprogramming to pluripotency.
    Takahashi K; Yamanaka S
    Nat Rev Mol Cell Biol; 2016 Mar; 17(3):183-93. PubMed ID: 26883003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells with Sleeping Beauty Transposon-Based Stable Gene Delivery.
    Sebe A; Ivics Z
    Methods Mol Biol; 2016; 1400():419-27. PubMed ID: 26895068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lineage Reprogramming of Fibroblasts into Proliferative Induced Cardiac Progenitor Cells by Defined Factors.
    Lalit PA; Salick MR; Nelson DO; Squirrell JM; Shafer CM; Patel NG; Saeed I; Schmuck EG; Markandeya YS; Wong R; Lea MR; Eliceiri KW; Hacker TA; Crone WC; Kyba M; Garry DJ; Stewart R; Thomson JA; Downs KM; Lyons GE; Kamp TJ
    Cell Stem Cell; 2016 Mar; 18(3):354-67. PubMed ID: 26877223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP Induces Human Naive Pluripotency.
    Qin H; Hejna M; Liu Y; Percharde M; Wossidlo M; Blouin L; Durruthy-Durruthy J; Wong P; Qi Z; Yu J; Qi LS; Sebastiano V; Song JS; Ramalho-Santos M
    Cell Rep; 2016 Mar; 14(10):2301-12. PubMed ID: 26947063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stressed out? Healing Tips for Newly Reprogrammed Neurons.
    Quadrato G; Zhang AC; Arlotta P
    Cell Stem Cell; 2016 Mar; 18(3):297-9. PubMed ID: 26942845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation.
    Lewandowski J; Kurpisz M
    Arch Immunol Ther Exp (Warsz); 2016 Oct; 64(5):349-70. PubMed ID: 26939778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFβ signaling regulates the choice between pluripotent and neural fates during reprogramming of human urine derived cells.
    Wang L; Li X; Huang W; Zhou T; Wang H; Lin A; Hutchins AP; Su Z; Chen Q; Pei D; Pan G
    Sci Rep; 2016 Mar; 6():22484. PubMed ID: 26935433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA3-dependent cellular reprogramming requires activation-domain dependent recruitment of a chromatin remodeler.
    Takaku M; Grimm SA; Shimbo T; Perera L; Menafra R; Stunnenberg HG; Archer TK; Machida S; Kurumizaka H; Wade PA
    Genome Biol; 2016 Feb; 17():36. PubMed ID: 26922637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raising the standards of stem cell line quality.
    Yaffe MP; Noggle SA; Solomon SL
    Nat Cell Biol; 2016 Mar; 18(3):236-7. PubMed ID: 26911906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pluripotent stem cells and livestock genetic engineering.
    Soto DA; Ross PJ
    Transgenic Res; 2016 Jun; 25(3):289-306. PubMed ID: 26894405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular features of cellular reprogramming and development.
    Smith ZD; Sindhu C; Meissner A
    Nat Rev Mol Cell Biol; 2016 Mar; 17(3):139-54. PubMed ID: 26883001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application for Lifestyle disease by iPS cells technologies].
    Takashima Y
    Clin Calcium; 2016 Mar; 26(3):433-9. PubMed ID: 26923982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Progress of Induced Pluripotent Stem Cells as Models of Parkinson's Disease.
    Kang JF; Tang BS; Guo JF
    Stem Cells Int; 2016; 2016():4126214. PubMed ID: 26880962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rad51 Regulates Reprogramming Efficiency through DNA Repair Pathway.
    Lee JY; Kim DK; Ko JJ; Kim KP; Park KS
    Dev Reprod; 2016 Jun; 20(2):163-9. PubMed ID: 27660832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Progress in Cell Reprogramming Technology for Cell Transplantation Therapy.
    Yamashita T; Abe K
    Neurol Med Chir (Tokyo); 2016; 56(3):97-101. PubMed ID: 26876902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical compound-based direct reprogramming for future clinical applications.
    Takeda Y; Harada Y; Yoshikawa T; Dai P
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29739872
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.